vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $93.5M, roughly 1.6× COMSCORE, INC.). COMSCORE, INC. runs the higher net margin — 3.2% vs -21.1%, a 24.3% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -19.2%). COMSCORE, INC. produced more free cash flow last quarter ($2.9M vs $-28.6M). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.

OPK vs SCOR — Head-to-Head

Bigger by revenue
OPK
OPK
1.6× larger
OPK
$148.5M
$93.5M
SCOR
Growing faster (revenue YoY)
SCOR
SCOR
+17.6% gap
SCOR
-1.5%
-19.2%
OPK
Higher net margin
SCOR
SCOR
24.3% more per $
SCOR
3.2%
-21.1%
OPK
More free cash flow
SCOR
SCOR
$31.5M more FCF
SCOR
$2.9M
$-28.6M
OPK
Faster 2-yr revenue CAGR
SCOR
SCOR
Annualised
SCOR
3.8%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OPK
OPK
SCOR
SCOR
Revenue
$148.5M
$93.5M
Net Profit
$-31.3M
$3.0M
Gross Margin
43.1%
41.0%
Operating Margin
-25.8%
7.0%
Net Margin
-21.1%
3.2%
Revenue YoY
-19.2%
-1.5%
Net Profit YoY
-322.8%
-3.7%
EPS (diluted)
$-0.04
$9.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
SCOR
SCOR
Q4 25
$148.5M
$93.5M
Q3 25
$151.7M
$88.9M
Q2 25
$156.8M
$89.4M
Q1 25
$150.0M
$85.7M
Q4 24
$183.6M
$94.9M
Q3 24
$173.6M
$88.5M
Q2 24
$182.2M
$85.8M
Q1 24
$173.7M
$86.8M
Net Profit
OPK
OPK
SCOR
SCOR
Q4 25
$-31.3M
$3.0M
Q3 25
$21.6M
$453.0K
Q2 25
$-148.4M
$-9.5M
Q1 25
$-67.6M
$-4.0M
Q4 24
$14.0M
$3.1M
Q3 24
$24.9M
$-60.6M
Q2 24
$-10.3M
$-1.7M
Q1 24
$-81.8M
$-1.1M
Gross Margin
OPK
OPK
SCOR
SCOR
Q4 25
43.1%
41.0%
Q3 25
32.9%
40.6%
Q2 25
31.5%
40.6%
Q1 25
28.4%
39.6%
Q4 24
46.1%
42.4%
Q3 24
23.1%
41.2%
Q2 24
28.4%
39.5%
Q1 24
24.2%
42.3%
Operating Margin
OPK
OPK
SCOR
SCOR
Q4 25
-25.8%
7.0%
Q3 25
31.7%
1.9%
Q2 25
-38.3%
-1.9%
Q1 25
-44.8%
-2.4%
Q4 24
-18.0%
4.1%
Q3 24
8.2%
-67.4%
Q2 24
-33.9%
-2.2%
Q1 24
-41.2%
-2.2%
Net Margin
OPK
OPK
SCOR
SCOR
Q4 25
-21.1%
3.2%
Q3 25
14.3%
0.5%
Q2 25
-94.7%
-10.6%
Q1 25
-45.1%
-4.7%
Q4 24
7.6%
3.3%
Q3 24
14.3%
-68.5%
Q2 24
-5.7%
-2.0%
Q1 24
-47.1%
-1.2%
EPS (diluted)
OPK
OPK
SCOR
SCOR
Q4 25
$-0.04
$9.50
Q3 25
$0.03
$-0.86
Q2 25
$-0.19
$-2.73
Q1 25
$-0.10
$-1.66
Q4 24
$0.02
$-0.47
Q3 24
$0.03
$-12.79
Q2 24
$-0.01
$-1.19
Q1 24
$-0.12
$-1.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
SCOR
SCOR
Cash + ST InvestmentsLiquidity on hand
$364.4M
$23.6M
Total DebtLower is stronger
$344.0M
$41.5M
Stockholders' EquityBook value
$1.3B
$111.4M
Total Assets
$1.9B
$407.7M
Debt / EquityLower = less leverage
0.27×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
SCOR
SCOR
Q4 25
$364.4M
$23.6M
Q3 25
$412.0M
$26.7M
Q2 25
$267.3M
$26.0M
Q1 25
$428.8M
$31.0M
Q4 24
$426.6M
$29.9M
Q3 24
$400.1M
$20.0M
Q2 24
$40.6M
$14.7M
Q1 24
$75.6M
$18.7M
Total Debt
OPK
OPK
SCOR
SCOR
Q4 25
$344.0M
$41.5M
Q3 25
$344.2M
$41.4M
Q2 25
$343.3M
$41.3M
Q1 25
$439.2M
$41.3M
Q4 24
$437.2M
$41.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
SCOR
SCOR
Q4 25
$1.3B
$111.4M
Q3 25
$1.3B
$-26.3M
Q2 25
$1.3B
$-21.7M
Q1 25
$1.3B
$-13.5M
Q4 24
$1.4B
$-8.3M
Q3 24
$1.4B
$-2.7M
Q2 24
$1.4B
$45.8M
Q1 24
$1.3B
$51.4M
Total Assets
OPK
OPK
SCOR
SCOR
Q4 25
$1.9B
$407.7M
Q3 25
$2.0B
$406.9M
Q2 25
$2.0B
$415.9M
Q1 25
$2.1B
$421.5M
Q4 24
$2.2B
$430.2M
Q3 24
$2.3B
$412.5M
Q2 24
$2.0B
$474.1M
Q1 24
$2.0B
$477.7M
Debt / Equity
OPK
OPK
SCOR
SCOR
Q4 25
0.27×
0.37×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
SCOR
SCOR
Operating Cash FlowLast quarter
$-25.9M
$3.2M
Free Cash FlowOCF − Capex
$-28.6M
$2.9M
FCF MarginFCF / Revenue
-19.3%
3.1%
Capex IntensityCapex / Revenue
1.8%
0.3%
Cash ConversionOCF / Net Profit
1.07×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$21.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
SCOR
SCOR
Q4 25
$-25.9M
$3.2M
Q3 25
$-34.6M
$9.5M
Q2 25
$-83.4M
$932.0K
Q1 25
$-34.6M
$9.1M
Q4 24
$-44.4M
$-10.0M
Q3 24
$-77.1M
$12.5M
Q2 24
$-26.4M
$8.7M
Q1 24
$-35.6M
$6.9M
Free Cash Flow
OPK
OPK
SCOR
SCOR
Q4 25
$-28.6M
$2.9M
Q3 25
$-37.8M
$9.4M
Q2 25
$-86.7M
$787.0K
Q1 25
$-37.7M
$8.7M
Q4 24
$-49.8M
$-10.3M
Q3 24
$-85.0M
$12.4M
Q2 24
$-33.7M
$8.5M
Q1 24
$-40.0M
$6.6M
FCF Margin
OPK
OPK
SCOR
SCOR
Q4 25
-19.3%
3.1%
Q3 25
-24.9%
10.5%
Q2 25
-55.3%
0.9%
Q1 25
-25.2%
10.1%
Q4 24
-27.1%
-10.8%
Q3 24
-49.0%
14.0%
Q2 24
-18.5%
10.0%
Q1 24
-23.0%
7.6%
Capex Intensity
OPK
OPK
SCOR
SCOR
Q4 25
1.8%
0.3%
Q3 25
2.1%
0.1%
Q2 25
2.1%
0.2%
Q1 25
2.1%
0.4%
Q4 24
2.9%
0.2%
Q3 24
4.6%
0.1%
Q2 24
4.0%
0.2%
Q1 24
2.6%
0.3%
Cash Conversion
OPK
OPK
SCOR
SCOR
Q4 25
1.07×
Q3 25
-1.60×
20.96×
Q2 25
Q1 25
Q4 24
-3.17×
-3.19×
Q3 24
-3.10×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

SCOR
SCOR

Transferred Over Time$77.1M83%
Research Insight Solutions$14.6M16%
Related Party$2.5M3%

Related Comparisons